GKOS
Glaukos Corporation
GKOS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
GKOS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Healthy | |
| Weak |
GKOS's revenue and cash flow are currently healthy, but its profitability and balance sheet are weak.
GKOS PE Valuation
GKOS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 170x next year's earnings.
GKOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect GKOS to return to profit, with revenue growing. However, they disagree widely on these estimates.
GKOS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.44 | — |
| Q3 2026 | -$2.96 | -$1.46 |
| Q2 2026 | -$3.27 | -$1.66 |
| Q1 2026 | -$3.30 | -$1.03 |
| Q4 2025 | -$3.28 | -$0.51 |
| Q3 2025 | -$1.50 | +$1.46 |
| Q2 2025 | -$1.61 | +$1.59 |
| Q1 2025 | -$2.27 | +$0.61 |
| Q4 2024 | -$2.77 | +$0.01 |
GKOS lost $2.96 per share over the past year, a bigger loss than the year before.
GKOS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $211M | +58% |
| Q2 2026 | $185.6M | +50% |
| Q1 2026 | $150.6M | +41% |
| Q4 2025 | $143.1M | +36% |
| Q3 2025 | $133.5M | +38% |
| Q2 2025 | $124.1M | +30% |
| Q1 2025 | $106.7M | +25% |
| Q4 2024 | $105.5M | +28% |
GKOS's revenue has grown year over year for 15 quarters in a row: $211M last quarter, up 58% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.4% | +13 points |
| Q2 2026 | -9.3% | +9 points |
| Q1 2026 | -13% | +6.2 points |
| Q4 2025 | -98% | -71 points |
| Q3 2025 | -12% | +13 points |
| Q2 2025 | -18% | +13 points |
| Q1 2025 | -19% | +26 points |
| Q4 2024 | -27% | +20 points |
GKOS's operating margin was 0.4% last quarter, up 13 points from the same quarter a year ago.
GKOS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36.5M | +$48.2M |
| Q2 2026 | $12.1M | +108% |
| Q1 2026 | -$16.5M | +$4M |
| Q4 2025 | $3.9M | +$5.2M |
| Q3 2025 | -$11.7M | -$689K |
| Q2 2025 | $5.8M | +$26.3M |
| Q1 2025 | -$20.5M | +$14.4M |
| Q4 2024 | -$1.2M | +$13.7M |
GKOS's free cash flow has turned positive after six years mostly in the red: $36M over the past year.
GKOS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +2.4M shares |
| 1 year | +6.6% | +3.8M shares |
| 3 years | +26% | +12.5M shares |
| 5 years | +24% | +11.9M shares |
| Available history | +49% | +20.1M shares |
GKOS has 61M diluted shares, up 6.6% from a year ago.
GKOS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 9.4x | High |
GKOS's net debt is about 9.3 years of its operating earnings (EBITDA).
GKOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.8 | Overbought |
| Stochastic | 84.2 | Overbought |
GKOS's weekly RSI is 75 (overbought) and its Stochastic is 84 (overbought).
GKOS PE vs Healthcare Sector
GKOS has no meaningful PE right now: it lost money over the past year.
GKOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $192.0 | 28% above |
| 20 week MA | $177.6 | 39% above |
| 50 week MA | $142.0 | 73% above |
| 100 week MA | $123.5 | 99% above |
| 200 week MA | $106.0 | 132% above |
GKOS is in an uptrend: it's above all five of its weekly moving averages, and 132% above its 200-week average.
GKOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.0 | $74.0 | +35% |
| 2021 | $74.0 | $46.8 | -37% |
| 2022 | $46.8 | $42.6 | -8.9% |
| 2023 | $42.6 | $79.5 | +86% |
| 2024 | $79.5 | $151.2 | +90% |
| 2025 | $151.2 | $116.2 | -23% |
| 2026 YTD | $116.2 | $246.0 | +112% |
GKOS is up 112% so far in 2026, after finishing lower in three of the previous six years.